Abstract
AbstractAlthough activating mutations of B-Raf are the most common genetic abnormalities in human melanomas, the mechanism by which mutant B-Raf transforms melanocytes is poorly understood. Here we show that the retinoblastoma tumor suppressor protein (pRB) is a direct target of B-Raf and is inactivated by phosphorylation in melanomas carrying B-Raf mutations. In contrast, pRB is undetectable in melanomas with wild-type B-Raf. Mutant B-Raf directly interacts with pRB and induces its phosphorylation at serine-249 and threonine-252 (S249/T252). Inhibition of B-Raf activity results in dephosphorylation of pRB at S249/T252 along with other sites in melanoma cells. S249/T252 are phosphorylated earlier than other sites during cell cycle entry of normal melanocytes. Blocking B-Raf activation precluded S249/T252 phosphorylation in mitogen-stimulated melanocytes, which was accompanied by the impaired phosphorylation of pRB at other sites. B-Raf enhanced CDK2-mediated pRB phosphorylation in an in vitro kinase assay. These results suggest that B-Raf is an initiating RB kinase, which triggers inactivation of pRB at the earliest step in the cell cycle entry of normal melanocytes, and its activating mutations cause deregulated growth, leading to the development of melanoma.
Highlights
Inhibition of B-Raf activity results in dephosphorylation of pRB at S249/T252 along with other sites in melanoma cells
As malignant melanoma is an extremely aggressive neoplasm with high mortality, considerable effort has been made to understand the molecular basis of the disease[2, 3]
These results indicate that pRB is inactivated in almost all melanoma cells by two mechanisms: hyperphosphorylation in B-Raf mutation-positive cases and loss of protein expression in BRaf mutation-negative cases
Summary
Inhibition of B-Raf activity results in dephosphorylation of pRB at S249/T252 along with other sites in melanoma cells. B-Raf is an initiating RB kinase, which triggers inactivation of pRB at the earliest step in the cell cycle entry of normal melanocytes, and its activating mutations cause deregulated growth, leading to the development of melanoma. PRB expression was absent or under the detection limit of immunoblotting in 5 out of 10 melanoma cell lines, whereas normal human epidermal melanocytes (NHEM) readily expressed RB protein.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
